MetaVia is trading 5.47% up in pre-market at $1.67 after closing at $1.58 on September 15, 2026, but the catalyst remains unclear.
- No confirmed September 16 company announcement, earnings release, analyst action, or regulatory catalyst was found.
- Recent preclinical DA-1726 coverage dates to September 9.
- Broader futures are only modestly higher ahead of the Federal Reserve decision.